1982
DOI: 10.1111/j.2042-7158.1982.tb04773.x
|View full text |Cite
|
Sign up to set email alerts
|

Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonists

Abstract: The antagonistic effects of the two benzomorphan opioid antagonists, Mr-1452 and Mr-2266 and their respective (+)-isomers Mr-1453 and Mr-2267 upon morphine, ethylketocyclazocine (EKC), D-ala2-D-leu5-enkephalinamide (BW 180-C) and oxotremorine (OTMN) antinociceptive activity in mice were investigated. Pretreatment with either Mr-1452 (2.0 mg Kg-1 i.p.) or Mr-2266 (2.0 mg kg-1 i.p.) significantly antagonized the antinociceptive effects of the three opioid agonists in the hot plate test, but were ineffective agai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1986
1986
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Substances showing significant analgesic activity in tail-immersion test implicate both spinal and supra-spinal analgesic pathways as this test was developed to detect such compounds [ 50 , 51 ]. Aside the peripheral mechanisms involving the inhibition of the release of prostaglandins, leukotrienes, bradykinins and other endogenous substances, nociception can be modulated centrally through complex processes involving the opioidergic, serotoninergic, dopaminergic and adrenergic mechanisms [ 52 – 55 ]. Pain threshold in the test was significantly increased by EthE and this suggests that it may be acting spinally or supra spinally to interfere with the nociception process.…”
Section: Discussionmentioning
confidence: 99%
“…Substances showing significant analgesic activity in tail-immersion test implicate both spinal and supra-spinal analgesic pathways as this test was developed to detect such compounds [ 50 , 51 ]. Aside the peripheral mechanisms involving the inhibition of the release of prostaglandins, leukotrienes, bradykinins and other endogenous substances, nociception can be modulated centrally through complex processes involving the opioidergic, serotoninergic, dopaminergic and adrenergic mechanisms [ 52 – 55 ]. Pain threshold in the test was significantly increased by EthE and this suggests that it may be acting spinally or supra spinally to interfere with the nociception process.…”
Section: Discussionmentioning
confidence: 99%